 | • レポートコード：QYR9NV13570 • 出版社/出版日：QYResearch / 2019年11月16日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・ヘルスケア |
| Single User | ￥525,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,050,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、経皮スコポラミンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、タブレットタイプ、シロップタイプ、注射タイプ、パッチタイプ、ゲルタイプに、用途別には、病院、クリニック、救急センター、その他にセグメント区分し、経皮スコポラミンの世界市場を分析しました。 ・エグゼクティブ・サマリー ・経皮スコポラミンの世界市場概要 ・経皮スコポラミンの製造コスト構成分析 ・経皮スコポラミンの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・経皮スコポラミンの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・経皮スコポラミンのセグメント分析（種類別） （タブレットタイプ、シロップタイプ、注射タイプ、パッチタイプ、ゲルタイプ） ・経皮スコポラミンのセグメント分析（用途別） （病院、クリニック、救急センター、その他） ・経皮スコポラミンの主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Baxter International Inc.、GlaxoSmithKline plc、Novartis AG、Perrigo Company plc.、Caleb Pharmaceuticals, Inc.、Myungmoon Pharma Co. LTD.、） ・経皮スコポラミンの市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global Transdermal Scopolamine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Transdermal Scopolamine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Transdermal Scopolamine market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Transdermal Scopolamine in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Transdermal Scopolamine manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Baxter International Inc.
GlaxoSmithKline plc
Novartis AG
Perrigo Company plc.
Caleb Pharmaceuticals, Inc.
Myungmoon Pharma Co. LTD.
…
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Tablet Type
Syrups Type
Injections Type
Patch Type
Gel Type
Segment by Application
Hospital
Clinic
Ambulance Center
Others
Table of Contents
Executive Summary
1 Industry Overview of Transdermal Scopolamine
1.1 Definition of Transdermal Scopolamine
1.2 Transdermal Scopolamine Segment by Type
1.2.1 Global Transdermal Scopolamine Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Tablet Type
1.2.3 Syrups Type
1.2.4 Injections Type
1.2.5 Patch Type
1.2.6 Gel Type
1.3 Transdermal Scopolamine Segment by Applications
1.3.1 Global Transdermal Scopolamine Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Ambulance Center
1.3.5 Others
1.4 Global Transdermal Scopolamine Overall Market
1.4.1 Global Transdermal Scopolamine Revenue (2014-2025)
1.4.2 Global Transdermal Scopolamine Production (2014-2025)
1.4.3 North America Transdermal Scopolamine Status and Prospect (2014-2025)
1.4.4 Europe Transdermal Scopolamine Status and Prospect (2014-2025)
1.4.5 China Transdermal Scopolamine Status and Prospect (2014-2025)
1.4.6 Japan Transdermal Scopolamine Status and Prospect (2014-2025)
1.4.7 Southeast Asia Transdermal Scopolamine Status and Prospect (2014-2025)
1.4.8 India Transdermal Scopolamine Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Transdermal Scopolamine
2.3 Manufacturing Process Analysis of Transdermal Scopolamine
2.4 Industry Chain Structure of Transdermal Scopolamine
3 Development and Manufacturing Plants Analysis of Transdermal Scopolamine
3.1 Capacity and Commercial Production Date
3.2 Global Transdermal Scopolamine Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Transdermal Scopolamine
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Transdermal Scopolamine Production and Capacity Analysis
4.2 Transdermal Scopolamine Revenue Analysis
4.3 Transdermal Scopolamine Price Analysis
4.4 Market Concentration Degree
5 Transdermal Scopolamine Regional Market Analysis
5.1 Transdermal Scopolamine Production by Regions
5.1.1 Global Transdermal Scopolamine Production by Regions
5.1.2 Global Transdermal Scopolamine Revenue by Regions
5.2 Transdermal Scopolamine Consumption by Regions
5.3 North America Transdermal Scopolamine Market Analysis
5.3.1 North America Transdermal Scopolamine Production
5.3.2 North America Transdermal Scopolamine Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Transdermal Scopolamine Import and Export
5.4 Europe Transdermal Scopolamine Market Analysis
5.4.1 Europe Transdermal Scopolamine Production
5.4.2 Europe Transdermal Scopolamine Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Transdermal Scopolamine Import and Export
5.5 China Transdermal Scopolamine Market Analysis
5.5.1 China Transdermal Scopolamine Production
5.5.2 China Transdermal Scopolamine Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Transdermal Scopolamine Import and Export
5.6 Japan Transdermal Scopolamine Market Analysis
5.6.1 Japan Transdermal Scopolamine Production
5.6.2 Japan Transdermal Scopolamine Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Transdermal Scopolamine Import and Export
5.7 Southeast Asia Transdermal Scopolamine Market Analysis
5.7.1 Southeast Asia Transdermal Scopolamine Production
5.7.2 Southeast Asia Transdermal Scopolamine Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Transdermal Scopolamine Import and Export
5.8 India Transdermal Scopolamine Market Analysis
5.8.1 India Transdermal Scopolamine Production
5.8.2 India Transdermal Scopolamine Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Transdermal Scopolamine Import and Export
6 Transdermal Scopolamine Segment Market Analysis (by Type)
6.1 Global Transdermal Scopolamine Production by Type
6.2 Global Transdermal Scopolamine Revenue by Type
6.3 Transdermal Scopolamine Price by Type
7 Transdermal Scopolamine Segment Market Analysis (by Application)
7.1 Global Transdermal Scopolamine Consumption by Application
7.2 Global Transdermal Scopolamine Consumption Market Share by Application (2014-2019)
8 Transdermal Scopolamine Major Manufacturers Analysis
8.1 Baxter International Inc.
8.1.1 Baxter International Inc. Transdermal Scopolamine Production Sites and Area Served
8.1.2 Baxter International Inc. Product Introduction, Application and Specification
8.1.3 Baxter International Inc. Transdermal Scopolamine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 GlaxoSmithKline plc
8.2.1 GlaxoSmithKline plc Transdermal Scopolamine Production Sites and Area Served
8.2.2 GlaxoSmithKline plc Product Introduction, Application and Specification
8.2.3 GlaxoSmithKline plc Transdermal Scopolamine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Novartis AG
8.3.1 Novartis AG Transdermal Scopolamine Production Sites and Area Served
8.3.2 Novartis AG Product Introduction, Application and Specification
8.3.3 Novartis AG Transdermal Scopolamine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Perrigo Company plc.
8.4.1 Perrigo Company plc. Transdermal Scopolamine Production Sites and Area Served
8.4.2 Perrigo Company plc. Product Introduction, Application and Specification
8.4.3 Perrigo Company plc. Transdermal Scopolamine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Caleb Pharmaceuticals, Inc.
8.5.1 Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Production Sites and Area Served
8.5.2 Caleb Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.5.3 Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Myungmoon Pharma Co. LTD.
8.6.1 Myungmoon Pharma Co. LTD. Transdermal Scopolamine Production Sites and Area Served
8.6.2 Myungmoon Pharma Co. LTD. Product Introduction, Application and Specification
8.6.3 Myungmoon Pharma Co. LTD. Transdermal Scopolamine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
9 Development Trend of Analysis of Transdermal Scopolamine Market
9.1 Global Transdermal Scopolamine Market Trend Analysis
9.1.1 Global Transdermal Scopolamine Market Size (Volume and Value) Forecast 2019-2025
9.2 Transdermal Scopolamine Regional Market Trend
9.2.1 North America Transdermal Scopolamine Forecast 2019-2025
9.2.2 Europe Transdermal Scopolamine Forecast 2019-2025
9.2.3 China Transdermal Scopolamine Forecast 2019-2025
9.2.4 Japan Transdermal Scopolamine Forecast 2019-2025
9.2.5 Southeast Asia Transdermal Scopolamine Forecast 2019-2025
9.2.6 India Transdermal Scopolamine Forecast 2019-2025
9.3 Transdermal Scopolamine Market Trend (Product Type)
9.4 Transdermal Scopolamine Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Transdermal Scopolamine Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Transdermal Scopolamine
Table Global Transdermal Scopolamine Production (K MT) Growth Rate Comparison by Types (2014-2025)
Figure Global Transdermal Scopolamine Production Market Share by Types in 2018
Figure Tablet Type Product Picture
Figure Syrups Type Product Picture
Figure Injections Type Product Picture
Figure Patch Type Product Picture
Figure Gel Type Product Picture
Table Global Transdermal Scopolamine Consumption (K MT) Comparison by Applications (2014-2025)
Figure Global Transdermal Scopolamine Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Ambulance Center
Figure Others
Figure Global Transdermal Scopolamine Revenue (Million USD) (2014-2025)
Figure Global Transdermal Scopolamine Production (K MT) (2014-2025)
Figure North America Transdermal Scopolamine Market Size (Million USD) (2014-2025)
Figure Europe Transdermal Scopolamine Market Size (Million USD) (2014-2025)
Figure China Transdermal Scopolamine Market Size (Million USD) (2014-2025)
Figure Japan Transdermal Scopolamine Market Size (Million USD) (2014-2025)
Figure Southeast Asia Transdermal Scopolamine Market Size (Million USD) (2014-2025)
Figure India Transdermal Scopolamine Market Size (Million USD) (2014-2025)
Table Transdermal Scopolamine Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Transdermal Scopolamine in 2018
Figure Manufacturing Process Analysis of Transdermal Scopolamine
Figure Industry Chain Structure of Transdermal Scopolamine
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Transdermal Scopolamine Manufacturing Plants Distribution
Table Transdermal Scopolamine Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Transdermal Scopolamine Capacity (K MT) of Major Manufacturers (2014-2019)
Table Transdermal Scopolamine Production (K MT) of Major Manufacturers (2014-2019)
Table Transdermal Scopolamine Production Market Share of Major Manufacturers (2014-2019)
Figure Transdermal Scopolamine Production Share by Manufacturers in 2018
Table Transdermal Scopolamine Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Transdermal Scopolamine Revenue Market Share of Major Manufacturers (2014-2019)
Figure Transdermal Scopolamine Revenue Share by Manufacturers in 2018
Table Transdermal Scopolamine Average Price (USD/MT) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Transdermal Scopolamine Production by Regions 2014-2019 (K MT)
Table Global Transdermal Scopolamine Production Market Share by Regions 2014-2019
Figure Global Transdermal Scopolamine Production Market Share by Regions in 2018
Table Global Transdermal Scopolamine Revenue by Regions 2014-2019 (Million USD)
Table Global Transdermal Scopolamine Revenue Market Share by Regions 2014-2019
Figure Global Transdermal Scopolamine Revenue Market Share by Regions in 2018
Table Global Transdermal Scopolamine Consumption by Regions 2014-2019 (K MT)
Table Global Transdermal Scopolamine Consumption Market Share by Regions 2014-2019
Figure North America Transdermal Scopolamine Production Growth Rate 2014-2019 (K MT)
Figure North America Transdermal Scopolamine Revenue Growth Rate 2014-2019 (Million USD)
Table North America Transdermal Scopolamine Production, Consumption Import and Export (K MT)
Figure Europe Transdermal Scopolamine Production Growth Rate 2014-2019 (K MT)
Figure Europe Transdermal Scopolamine Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Transdermal Scopolamine Production, Consumption Import and Export (K MT)
Figure China Transdermal Scopolamine Production Growth Rate 2014-2019 (K MT)
Figure China Transdermal Scopolamine Revenue Growth Rate 2014-2019 (Million USD)
Table China Transdermal Scopolamine Production, Consumption Import and Export (K MT)
Figure Japan Transdermal Scopolamine Production Growth Rate 2014-2019 (K MT)
Figure Japan Transdermal Scopolamine Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Transdermal Scopolamine Production, Consumption Import and Export (K MT)
Figure Southeast Asia Transdermal Scopolamine Production Growth Rate 2014-2019 (K MT)
Figure Southeast Asia Transdermal Scopolamine Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Transdermal Scopolamine Production, Consumption Import and Export (K MT)
Figure India Transdermal Scopolamine Production Growth Rate 2014-2019 (K MT)
Figure India Transdermal Scopolamine Revenue Growth Rate 2014-2019 (Million USD)
Table India Transdermal Scopolamine Production, Consumption Import and Export (K MT)
Figure Global Consumption Transdermal Scopolamine Market Share by Application (2014-2019)
Figure Global Value (Consumption) Transdermal Scopolamine Market Share by Application (2014-2019)
Table Baxter International Inc. Transdermal Scopolamine Production Sites and Area Served
Table Baxter International Inc. Transdermal Scopolamine Product Introduction, Application and Specification
Table Baxter International Inc. Transdermal Scopolamine Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Baxter International Inc. Transdermal Scopolamine Production Growth Rate (2014-2019)
Table Baxter International Inc. Transdermal Scopolamine Production Market Share (2014-2019)
Figure Baxter International Inc. Transdermal Scopolamine Revenue Market Share (2014-2019)
Table Baxter International Inc. Transdermal Scopolamine Main Business and Markets Served
Table GlaxoSmithKline plc Transdermal Scopolamine Production Sites and Area Served
Table GlaxoSmithKline plc Transdermal Scopolamine Product Introduction, Application and Specification
Table GlaxoSmithKline plc Transdermal Scopolamine Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table GlaxoSmithKline plc Transdermal Scopolamine Production Growth Rate (2014-2019)
Table GlaxoSmithKline plc Transdermal Scopolamine Production Market Share (2014-2019)
Figure GlaxoSmithKline plc Transdermal Scopolamine Revenue Market Share (2014-2019)
Table GlaxoSmithKline plc Transdermal Scopolamine Main Business and Markets Served
Table Novartis AG Transdermal Scopolamine Production Sites and Area Served
Table Novartis AG Transdermal Scopolamine Product Introduction, Application and Specification
Table Novartis AG Transdermal Scopolamine Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Novartis AG Transdermal Scopolamine Production Growth Rate (2014-2019)
Table Novartis AG Transdermal Scopolamine Production Market Share (2014-2019)
Figure Novartis AG Transdermal Scopolamine Revenue Market Share (2014-2019)
Table Novartis AG Transdermal Scopolamine Main Business and Markets Served
Table Perrigo Company plc. Transdermal Scopolamine Production Sites and Area Served
Table Perrigo Company plc. Transdermal Scopolamine Product Introduction, Application and Specification
Table Perrigo Company plc. Transdermal Scopolamine Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Perrigo Company plc. Transdermal Scopolamine Production Growth Rate (2014-2019)
Table Perrigo Company plc. Transdermal Scopolamine Production Market Share (2014-2019)
Figure Perrigo Company plc. Transdermal Scopolamine Revenue Market Share (2014-2019)
Table Perrigo Company plc. Transdermal Scopolamine Main Business and Markets Served
Table Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Production Sites and Area Served
Table Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Product Introduction, Application and Specification
Table Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Production Growth Rate (2014-2019)
Table Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Production Market Share (2014-2019)
Figure Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Revenue Market Share (2014-2019)
Table Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Main Business and Markets Served
Table Myungmoon Pharma Co. LTD. Transdermal Scopolamine Production Sites and Area Served
Table Myungmoon Pharma Co. LTD. Transdermal Scopolamine Product Introduction, Application and Specification
Table Myungmoon Pharma Co. LTD. Transdermal Scopolamine Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Myungmoon Pharma Co. LTD. Transdermal Scopolamine Production Growth Rate (2014-2019)
Table Myungmoon Pharma Co. LTD. Transdermal Scopolamine Production Market Share (2014-2019)
Figure Myungmoon Pharma Co. LTD. Transdermal Scopolamine Revenue Market Share (2014-2019)
Table Myungmoon Pharma Co. LTD. Transdermal Scopolamine Main Business and Markets Served
Figure Global Transdermal Scopolamine Production (K MT) Growth Rate Forecast 2019-2025
Figure Global Transdermal Scopolamine Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Transdermal Scopolamine Sales Price (USD/MT) Forecast 2019-2025
Figure North America Transdermal Scopolamine Production Growth Rate Forecast 2019-2025 (K MT)
Figure North America Transdermal Scopolamine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Transdermal Scopolamine Production Growth Rate Forecast 2019-2025 (K MT)
Figure Europe Transdermal Scopolamine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Transdermal Scopolamine Production Growth Rate Forecast 2019-2025 (K MT)
Figure China Transdermal Scopolamine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Transdermal Scopolamine Production Growth Rate Forecast 2019-2025 (K MT)
Figure Japan Transdermal Scopolamine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Transdermal Scopolamine Production Growth Rate Forecast 2019-2025 (K MT)
Figure Southeast Asia Transdermal Scopolamine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Transdermal Scopolamine Production Growth Rate Forecast 2019-2025 (K MT)
Figure India Transdermal Scopolamine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K MT) of Transdermal Scopolamine by Type (2019-2025)
Table Global Consumption (K MT) of Transdermal Scopolamine by Application (2019-2025)
Table Transdermal Scopolamine Distributors List
Table Transdermal Scopolamine Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
経皮スコポラミンのグローバル市場調査 2019年 The global Transdermal Scopolamine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Transdermal Scopolamine volume and value at global level, regional level and company level. From a global perspecti…- ニトログリセリン経皮パッチのグローバル市場調査 2019年 The global Nitroglycerin Transdermal Patches market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Nitroglycerin Transdermal Patches volume and value at global level, regional level and company level. Fro…
- ニコチン経皮パッチのグローバル市場調査 2019年 The global Nicotine Transdermal Patches market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Nicotine Transdermal Patches volume and value at global level, regional level and company level. From a global…
- ロチゴチン経皮パッチのグローバル市場調査 2019年 The global Rotigotine Transdermal Patches market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Rotigotine Transdermal Patches volume and value at global level, regional level and company level. From a gl…
- ロチゴチン経皮パッチのグローバル市場調査 2019年 The global Rotigotine Transdermal Patches market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Rotigotine Transdermal Patches volume and value at global level, regional level and company level. From a gl…